| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS541911 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS557635 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS611729 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS614032 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS622104 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS613402 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS625513 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS625897 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS649674 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS652167 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS640921 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach, intestinal type from ORIGENE TECHNOLOGIES | CS536435 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach, intestinal type (protein lysate) from ORIGENE TECHNOLOGIES | CP536436 | 150 ug | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach from ORIGENE TECHNOLOGIES | CS814522 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach, metastatic from ORIGENE TECHNOLOGIES | CS708994 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach, metastatic from ORIGENE TECHNOLOGIES | CS716678 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach, metastatic from ORIGENE TECHNOLOGIES | CS702723 | 5x5um | ORIGENE TECHNOLOGIES |
| Human keratin 2 (KRT2), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760673 | 50 ug | ORIGENE TECHNOLOGIES |
| Human Stomach; Adenocarcinoma of stomach, metastatic from ORIGENE TECHNOLOGIES | CS810837 | 5x5um | ORIGENE TECHNOLOGIES |
| Human keratinocyte differentiation-associated protein (KRTDAP) from ORIGENE TECHNOLOGIES | TP323306 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ketohexokinase (fructokinase) (KHK), transcript variant a from ORIGENE TECHNOLOGIES | TP302424 | 20 ug | ORIGENE TECHNOLOGIES |
| Human 3-ketodihydrosphingosine reductase (KDSR) from ORIGENE TECHNOLOGIES | TP301153 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ketohexokinase (fructokinase) (KHK), transcript variant a from ORIGENE TECHNOLOGIES | TP721095 | 10 ug | ORIGENE TECHNOLOGIES |
| Human KH domain containing, RNA binding, signal transduction associated 1 (KHDRBS1) from ORIGENE TECHNOLOGIES | TP300263 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KH domain containing, RNA binding, signal transduction associated 2 (KHDRBS2) from ORIGENE TECHNOLOGIES | TP305428 | 20 ug | ORIGENE TECHNOLOGIES |
| Human keratinocyte associated protein 3 (KRTCAP3) from ORIGENE TECHNOLOGIES | TP310983 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KH homology domain containing 1 (KHDC1), full length from ORIGENE TECHNOLOGIES | TP760142 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ketohexokinase (fructokinase) (KHK), transcript variant b from ORIGENE TECHNOLOGIES | TP323488 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA0247 (KIAA0247) from ORIGENE TECHNOLOGIES | TP309240 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA0494 (KIAA0494) from ORIGENE TECHNOLOGIES | TP300565 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KH-type splicing regulatory protein (KHSRP) from ORIGENE TECHNOLOGIES | TP317220 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA0495 (KIAA0495) from ORIGENE TECHNOLOGIES | TP310801 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA0319 (KIAA0319) from ORIGENE TECHNOLOGIES | TP314212 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA0907 (KIAA0907) from ORIGENE TECHNOLOGIES | TP309536 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA0562 (KIAA0562) from ORIGENE TECHNOLOGIES | TP312710 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA1045 (KIAA1045) from ORIGENE TECHNOLOGIES | TP312001 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA1530 (KIAA1530) from ORIGENE TECHNOLOGIES | TP310690 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA1274 (KIAA1274) from ORIGENE TECHNOLOGIES | TP314853 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA1279 (KIAA1279) from ORIGENE TECHNOLOGIES | TP304278 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA1609 (KIAA1609) from ORIGENE TECHNOLOGIES | TP309287 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA1715 (KIAA1715) from ORIGENE TECHNOLOGIES | TP313378 | 20 ug | ORIGENE TECHNOLOGIES |
| Human KIAA1618 (KIAA1618) from ORIGENE TECHNOLOGIES | TP302317 | 20 ug | ORIGENE TECHNOLOGIES |
| CD44 molecule (Indian blood group) (CD44), transcript variant 4 from ORIGENE TECHNOLOGIES | LY424334 | 100 ug | ORIGENE TECHNOLOGIES |
| CD207 molecule, langerin (CD207) from ORIGENE TECHNOLOGIES | LY402461 | 100 ug | ORIGENE TECHNOLOGIES |
| Human KIAA1737 (KIAA1737) from ORIGENE TECHNOLOGIES | TP306226 | 20 ug | ORIGENE TECHNOLOGIES |
| CD5 molecule-like (CD5L) from ORIGENE TECHNOLOGIES | LY401793 | 100 ug | ORIGENE TECHNOLOGIES |
| CD99 molecule-like 2 (CD99L2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410504 | 100 ug | ORIGENE TECHNOLOGIES |
| CD300 molecule-like family member b (CD300LB) from ORIGENE TECHNOLOGIES | LY406296 | 100 ug | ORIGENE TECHNOLOGIES |
| CD99 molecule-like 2 (CD99L2), transcript variant 4 from ORIGENE TECHNOLOGIES | LY432656 | 100 ug | ORIGENE TECHNOLOGIES |
| CD300 molecule-like family member f (CD300LF) from ORIGENE TECHNOLOGIES | LY408391 | 100 ug | ORIGENE TECHNOLOGIES |